Literature DB >> 6450575

Development of systemic lupus erythematosus after thymectomy for myasthenia gravis. Studies of suppressor cell function.

L H Calabrese, J F Bach, T Currie, D Vidt, J Clough, R S Krakauer.   

Abstract

Systemic lupus erythematosus developed in an 18-year-old man three years after thymectomy for myasthenia gravis. The patient had considerable defects in suppressor cell function that seemed to be partially reversed in vitro by the addition of thymic hormone.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6450575

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  7 in total

Review 1.  The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature.

Authors:  M Jallouli; D Saadoun; B Eymard; G Leroux; J Haroche; D Le Thi Huong; C De Gennes; C Chapelon; O Benveniste; B Wechsler; P Cacoub; Z Amoura; J C Piette; N Costedoat-Chalumeau
Journal:  J Neurol       Date:  2011-12-08       Impact factor: 4.849

2.  Anti-Sm-RNP activity in sera of patients with rheumatic and autoimmune diseases.

Authors:  M Abu-Shakra; M Krup; H Slor; Y Shoenfeld
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

Review 3.  Systemic lupus erythematosus after thymectomy for myasthenia gravis: a case report and review of the literature.

Authors:  Hyder A Omar; Mohammed A Alzahrani; Ali A A Al Bshabshe; Alhussain Assiri; Medhat Shalaby; Ahmad Dwedar; Saad Rezk Abdulwahed; Mahmoud Rezk-Abd-Elwahed Hussein
Journal:  Clin Exp Nephrol       Date:  2010-01-07       Impact factor: 2.801

Review 4.  The association of systemic lupus erythematosus and myasthenia gravis.

Authors:  G Vaiopoulos; P P Sfikakis; V Kapsimali; K Boki; P Panayiotidis; A Aessopos; G C Tsokos; P Kaklamanis
Journal:  Postgrad Med J       Date:  1994-10       Impact factor: 2.401

5.  Appearance of systemic lupus erythematosus in patients with myasthenia gravis following thymectomy: two case reports.

Authors:  Mi Jeong Park; Yun A Kim; Shin Seok Lee; Byeong Chae Kim; Myeong Kyu Kim; Ki Hyun Cho
Journal:  J Korean Med Sci       Date:  2004-02       Impact factor: 2.153

6.  Heterozygous C2 deficiency associated with angioedema, myasthenia gravis, and systemic lupus erythematosus.

Authors:  J Efthimiou; D D'Cruz; P Kaplan; D Isenberg
Journal:  Ann Rheum Dis       Date:  1986-05       Impact factor: 19.103

7.  Risk of incident autoimmune diseases in patients with thymectomy.

Authors:  Tzu-Min Lin; Yu-Sheng Chang; Tsung-Yun Hou; Hui-Ching Hsu; Sheng-Hung Lin; Wei-Sheng Chen; Pei-I Kuo; Yi-Chun Lin; Jin-Hua Chen; Chi-Ching Chang
Journal:  Ann Clin Transl Neurol       Date:  2020-06-01       Impact factor: 4.511

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.